## MLM: Martin Marietta Materials, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 0.2% below STRENGTH zone (4.0-10.0%); PEG 3.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($599.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. How Investors Are Reacting To Martin Marietta Materials (MLM) Shift Toward High-Margin Aggregates Business**
- Source: Simply Wall Street | 20251203T000715 | Somewhat-Bullish | Relevance: 100%
- Martin Marietta Materials (MLM) is shifting its focus to its high-margin aggregates business, evidenced by an asset exchange with Quikrete Holdings Inc. and increased full-year 2025 Adjusted EBITDA guidance. This strategic pivot aims to capitalize on infrastructure investments and strong demand in construction, with the company projected to reach $8.4 billion in revenue and $1.6 billion in earnings by 2028. Investors are weighing the potential for margin expansion against ongoing uncertainties in public infrastructure funding.

**2. Is Martin Marietta Materials Stock Underperforming the Nasdaq?**
- Source: Barchart.com | 20251205T131041 | Neutral | Relevance: 100%
- Martin Marietta Materials (MLM) is a large-cap building materials company that has underperformed the Nasdaq Composite ($NASX) over the past three months and year-to-date. Despite missing Q3 earnings and revenue estimates, the stock is trading above its 50-day and 200-day moving averages, indicating a bullish trend. Analysts have a "Moderate Buy" rating for MLM, predicting a 9.1% upside potential.

**3. Why Is Martin Marietta (MLM) Up 0.9% Since Last Earnings Report?**
- Source: Yahoo Finance Singapore | 20251204T160806 | Neutral | Relevance: 100%
- Martin Marietta (MLM) shares have risen 0.9% since its last earnings report, outperforming the S&P 500 despite missing Q3 2025 earnings and revenue estimates. The company's performance was bolstered by strong infrastructure activity and nonresidential construction, with an optimistic long-term outlook for residential demand. Martin Marietta also revised its 2025 guidance upwards for total revenues, adjusted EBITDA, and aggregate gross profit, though estimates have trended downward recently.

**4. How Investors Are Reacting To Martin Marietta Materials (MLM) Shift Toward High-Margin Aggregates Business**
- Source: Sahm | 20251203T150925 | Somewhat-Bullish | Relevance: 100%
- Martin Marietta Materials announced a strategic shift towards its high-margin aggregates business, highlighted by an asset exchange with Quikrete Holdings Inc. This move is supported by record profitability in aggregates and a raised full-year 2025 Adjusted EBITDA guidance, as the company anticipates continued benefits from infrastructure investments. Investors are evaluating how this focus on margin expansion through portfolio optimization will impact the company's investment outlook, though concerns about public infrastructure funding remain.

**5. CW Advisors LLC Trims Stake in Martin Marietta Materials, Inc. $MLM**
- Source: MarketBeat | 20251203T101553 | Neutral | Relevance: 100%
- CW Advisors LLC reduced its stake in Martin Marietta Materials, Inc. (NYSE:MLM) by 9.6% in the second quarter, bringing its total holdings to 56,797 shares valued at $31.18 million. This comes as other institutional investors have either purchased new positions or adjusted their stakes in the construction materials company. The article also provides financial data for Martin Marietta Materials, including its recent stock performance, market capitalization, earnings per share, and dividend information, alongside various analyst ratings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Morgan Stanley | $660 | $610 | +8% |
| 2025-11-11 | Stifel | $681 | $637 | +7% |
| 2025-11-11 | JP Morgan | $700 | $670 | +4% |
| 2025-11-07 | UBS | $723 | $705 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Morgan Stanley | main | Overweight |
| 2025-11-11 | Stifel | main | Buy |
| 2025-11-11 | JP Morgan | main | Neutral |
| 2025-11-07 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.12M) |
| Sells | 7 ($0.61M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+1.3%)
- JPMORGAN CHASE & CO: 9.7% (+98.6%)
- Blackrock Inc.: 6.9% (-1.8%)
- FMR, LLC: 4.8% (-4.3%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.58 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 17%). Balance sheet: strong liquidity (3.0x). Analyst sentiment positive (4 raises, avg +6%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.9B |
| Beta | 1.16 |
| 52W Range | $441.95 - $665.18 |
| Short Interest | 3.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.58 |
| Forward P/E | 28.1 |
| Current P/E | 33.4 |
| YoY Growth | 18.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.2% (minimal 5-day change). Below STRENGTH zone by 3.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.36), confirming momentum. RSI neutral at 58. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.21% (CS: 56) | Neutral |
| RSI_14 | 57.6 | Neutral |
| MACD Histogram | 2.36 | Bullish |
| vs SMA20 | 1.024x | Above |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 1.106x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $624.37
- **Stop Loss:** $599.49 (4.0% risk)
- **Target:** $649.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $12,487.40
- **Portfolio %:** 12.49%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-11 (Est: $4.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.68 | $6.85 | +2.5% |
| 2025Q2 | $5.26 | $5.43 | +3.2% |
| 2025Q1 | $1.88 | $1.90 | +1.1% |
| 2024Q4 | $4.56 | $4.81 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*